Emmanuelle Fantino Selected Research

Withholding Treatment

6/2010

CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuelle Fantino Research Topics

Disease

7	Infections 01/2022 - 02/2014
6	Inflammation (Inflammations) 01/2022 - 02/2014
4	Neoplasms (Cancer) 12/2011 - 08/2009
3	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 03/2017
3	Lung Diseases (Lung Disease) 01/2019 - 02/2014
2	Asthma (Bronchial Asthma) 01/2017 - 10/2014
1	Virus Diseases (Viral Diseases) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2014
1	Colonic Neoplasms (Colon Cancer) 12/2011
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Primary Myelofibrosis (Myelosclerosis) 06/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2009
1	Hematologic Neoplasms (Hematological Malignancy) 03/2009
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2004
1	Alzheimer Disease (Alzheimer's Disease) 08/2004
1	Schizophrenia (Dementia Praecox) 08/2004

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2020 - 03/2009
3	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2014
3	CYT997IBA 12/2011 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 03/2017 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 08/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	GuanineIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	PentosesIBA 01/2022
1	NucleosidesIBA 01/2022
1	lenabasum (ajulemic acid)IBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2019
1	InflammasomesIBA 01/2019
1	EP2 Subtype Prostaglandin E ReceptorsIBA 01/2019
1	CatalaseIBA 01/2019
1	AmphiregulinIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Interleukin-13IBA 07/2017
1	glutathione sulfonamideIBA 03/2017
1	AllantoinIBA 03/2017
1	Uric Acid (Urate)IBA 03/2017
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 03/2017
1	Glutathione (Reduced Glutathione)IBA 03/2017
1	CaspasesIBA 01/2017
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2017
1	SmokeIBA 12/2014
1	InterferonsIBA 10/2014
1	ChitinasesIBA 02/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2014
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 12/2011
1	Dihydrotachysterol (AT 10)IBA 12/2011
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2011
1	Janus Kinase 2IBA 06/2010
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 06/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2009
1	Tubulin ModulatorsIBA 08/2009
1	Janus KinasesIBA 03/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2009
1	Presenilin-2IBA 08/2004

Therapy/Procedure

1	Therapeutics 01/2017
1	Withholding Treatment 06/2010